万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.journals.elsevier.com/comparative-biochemistry-and-physiology-part-c-toxicology-and-pharmacology/
3、投稿网址：
https://www.editorialmanager.com/cbpc/default.aspx
4、期刊刊期：月刊，一年出版12期。
2021年6月4日星期五
投稿须知【官网信息】
Guide for Authors
Please bookmark this URL: https://www.elsevier.com/locate/cbpc
The journal publishes original articles emphasizing comparative and environmental aspects of the physiology, biochemistry, molecular biology, pharmacology, toxicology and endocrinology of animals. Adaptation and evolution as organizing principles are encouraged. Studies on other organisms will be considered if approached in a comparative context.
Part A. Molecular and Integrative Physiology covers molecular, cellular, integrative, and ecological physiology. Topics include bioenergetics, circulation, development, excretion, ion regulation, endocrinology, neurobiology, nutrition, respiration, and thermal biology. Studies on regulatory mechanisms at any level or organization such as signal transduction and cellular interactions and control of behaviour are encouraged.
Part B. Biochemistry and Molecular Biology covers biochemical and molecular biological aspects of metabolism, enzymology, regulation, nutrition, signal transduction, promoters, gene structure and regulation, metabolite and cell constituents, macromolecular structures, adaptational mechanisms and evolutionary principles.
Part C. Toxicology and Pharmacology covers chemical and drug action at different levels of organization, biotransformation of xenobiotics, mechanisms of toxicity, including reactive oxygen species and carcinogenesis, endocrine disruptors, natural products chemistry, and signal transduction. A molecular approach to these fields is encouraged. Measured rather than nominal exposure concentrations of toxicants must be reported whenever possible. For water-borne exposures of aquatic organisms, reporting of detailed chemistry data for the exposure waters is encouraged. When reporting data obtained from bioassays (e.g., LC50 tests), raw data (i.e., the value of the measured biological response variable(s) for each treatment and each observation time) should be submitted as online supplementary material.
Part D. Genomics and Proteomics covers the broader comprehensive approaches to comparative biochemistry and physiology that can be generally termed as "-omics", e.g., genomics, functional genomics (transcriptomics), proteomics, metabolomics, and underlying bioinformatics. Papers dealing with fundamental aspects and hypotheses in comparative physiology and biochemistry are encouraged rather than studies whose main focus is purely technical of methodological.
Naturally, a certain degree of overlap exists between the different sections, and the final decision as to where a particular manuscript will be published after passing the rigorous review process lies with the editorial office.
Types of articles
A Research Paper is a paper that focuses on an experimental question of broad interest to the comparative physiology community.
Word count (excluding references): typically 4000 -8000 words, with at least 2 figures / tables.
Papers are normally subdivided into sections titled: Abstract, Introduction, Materials and Methods, Results, Discussion, and References. Results and discussion may be combined if appropriate.
A Short Communication is like a Regular Article in scope, but is of a nature that a complete story can be presented in a brief communication. As Short Communications are expected to have higher than average impact on the field rather than report on incremental research, they will receive prioritized and rapid publication.
Word count: less than 3000 words, with no more than 2 figures / tables.
Each paper will begin with "Short Communication:" followed by the title.
The paper includes and Abstract, but is otherwise not subdivided into sections.
A Methods article is focused on applying a novel technology or approach that would inform the CBP readership about a novel technology applied to a comparative physiology question.
Word count: typically less than 3000 words, with no more than 2 figures / tables.
Each paper will begin with "Methods:" followed by the title.
The paper is subdivided into abstract, background, methods, applications.
An Invited Review is a submission that is solicited by an Editor-in-Chief, Associate Editor or member of the Editorial Board. An invited review is published with free access for the first year.
Word count: typically 6,000- 10,000, with 2 or more figures / tables.
Each paper will begin with "Invited Review:" followed by the title.
A Graphical Review article can be submitted without a specific invitation, but authors are encouraged to request input form the appropriate Editor-in-Chief to ensure that the paper falls within the scope of the journal. This article type is meant to summarize the most recent status of a specific topic mainly through illustrations. The text and the number of references allowed are limited to favor a focus on the figures. The article structure should be as follows:
Abstract: up to 250 words.
Body (exclusive of figure legends): up to 2000 words, double-spaced, Arial font, size 11
3-5 color schemes/figures summarizing the state of the specific topic covered. Each figure needs to be self-explanatory, including sufficient annotations to allow the readers to quickly grasp the content of the figure
Figure legends must be straight to the point, providing additional details which deepen the message of the figure itself. Please ensure that the reader, who may not be a direct expert in the field, can easily grasp the information provided.
References: no more than 25 key articles that exemplify the most significant recent advances in the field
Illustrations: Authors are expected to use their own illustration resources.They may also make use of Elsevier's Illustration Services to ensure the best presentation of their images, in accordance with all technical requirements.
An example of GR is available here
A Review article can be submitted without a specific invitation, but authors are encouraged to request input form the appropriate Editor-in-Chief to ensure that the paper falls within the scope of the journal. Each paper will begin with "Review" followed by the title. The paper is not subdivided into sections. A review is published with free access for the first year.
Word count: typically 6,000- 10,000 words, with 2-4 figures or tables
Each paper will begin with "Review:" followed by the title.
A Commentary is a more narrowly written review, typically focused on a specific concept of immediate importance to the discipline. While it is expected that authors survey the peer-reviewed literature on the subject, a Commentary paper offers more room for more speculative consideration of a topic. Authors are advised to contact the Editor-in-Chief to determine if your topic is suitable.
Word count: less than 3000 words, with no more than 2 figures / tables.
Each paper will begin with "Commentary:" followed by the title.
The paper is not normally subdivided into sections
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author Rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Referees
The slowest part of the review process is finding reviewers who meet the criteria for expertise and have sufficient time to take on these onerous tasks. It will accelerate the review process if you suggest reviewers that are suitable, using the following guidelines.
Free from conflict: Referees should be arms-length from the authors. This means they should be from different institutions and with no history of meaningful collaboration within 2 years.
International representation: At least two of your suggestions should be from outside your home country. At least one referee should be from our Editorial Board
Justification: Referees are not selected unless the editors can find evidence of their expertise through a publication record or institutional homepage. A URL can help the Editors verify that the recommended reviewer is appropriate.
Editors use the recommended reviewers as an indication of whether the authors believe their work can withstand scrutiny by international peers. If you cannot identify five expert, arms-length reviewers from different countries, then we see this as a sign that your study may not have broad appeal to our international readership, and may not be sent out for review.
……
更多详情：
https://www.elsevier.com/journals/comparative-biochemistry-and-physiology-part-c-toxicology-and-pharmacology/1532-0456/guide-for-authors
